Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Angew Chem Int Ed Engl ; 62(1): e202210140, 2023 01 02.
Artículo en Inglés | MEDLINE | ID: mdl-36321387

RESUMEN

Ultra-small gold nanoparticles (UAuNPs) are extremely interesting for applications in nanomedicine thanks to their good stability, biocompatibility, long circulation time and efficient clearance pathways. UAuNPs engineered with glycans (Glyco-UAuNPs) emerged as excellent platforms for many applications since the multiple copies of glycans can mimic the multivalent effect of glycoside clusters. Herein, we unravel a straightforward photo-induced synthesis of Glyco-UAuNPs based on a reliable and robust microfluidic approach. The synthesis occurs at room temperature avoiding the use of any further chemical reductant, templating agents or co-solvents. Exploiting 1 H NMR spectroscopy, we showed that the amount of thiol-ligand exposed on the UAuNPs is linearly correlated to the ligand concentration in the initial mixture. The results pave the way towards the development of a programmable synthetic approach, enabling an accurate design of the engineered UAuNPs or smart hybrid nano-systems.


Asunto(s)
Nanopartículas del Metal , Nanopartículas , Oro/química , Nanopartículas del Metal/química , Microfluídica , Ligandos , Nanopartículas/química , Polisacáridos/química
2.
Mol Pharm ; 17(10): 3885-3899, 2020 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-32787269

RESUMEN

Boron neutron capture therapy (BNCT) for cancer is on the rise worldwide due to recent developments of in-hospital neutron accelerators which are expected to revolutionize patient treatments. There is an urgent need for improved boron delivery agents, and herein we have focused on studying the biochemical foundations upon which a successful GLUT1-targeting strategy to BNCT could be based. By combining synthesis and molecular modeling with affinity and cytotoxicity studies, we unravel the mechanisms behind the considerable potential of appropriately designed glucoconjugates as boron delivery agents for BNCT. In addition to addressing the biochemical premises of the approach in detail, we report on a hit glucoconjugate which displays good cytocompatibility, aqueous solubility, high transporter affinity, and, crucially, an exceptional boron delivery capacity in the in vitro assessment thereby pointing toward the significant potential embedded in this approach.


Asunto(s)
Terapia por Captura de Neutrón de Boro/métodos , Boro/administración & dosificación , Portadores de Fármacos/efectos de la radiación , Glucosa/efectos de la radiación , Isótopos/administración & dosificación , Neoplasias/radioterapia , Boro/farmacocinética , Línea Celular Tumoral , Portadores de Fármacos/síntesis química , Portadores de Fármacos/farmacocinética , Liberación de Fármacos/efectos de la radiación , Glucosa/análogos & derivados , Glucosa/síntesis química , Glucosa/farmacocinética , Transportador de Glucosa de Tipo 1/metabolismo , Humanos , Isótopos/farmacocinética , Simulación del Acoplamiento Molecular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA